PC
ALXN

Polar Capital’s Alexion Pharmaceuticals Inc ALXN Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2020
Q3
$40.1M Buy
350,000
+85,000
+32% +$9.73M 0.3% 89
2020
Q2
$29.7M Sell
265,000
-80,934
-23% -$9.08M 0.26% 104
2020
Q1
$31.1M Sell
345,934
-90,000
-21% -$8.08M 0.33% 92
2019
Q4
$47.1M Buy
435,934
+110,934
+34% +$12M 0.41% 72
2019
Q3
$31.8M Sell
325,000
-353,592
-52% -$34.6M 0.29% 108
2019
Q2
$88.9M Buy
678,592
+219,500
+48% +$28.8M 0.78% 29
2019
Q1
$62.1M Buy
459,092
+43,092
+10% +$5.83M 0.58% 53
2018
Q4
$40.5M Buy
416,000
+15,000
+4% +$1.46M 0.43% 75
2018
Q3
$55.7M Buy
401,000
+186,000
+87% +$25.9M 0.47% 67
2018
Q2
$26.7K Buy
215,000
+90,000
+72% +$11.2K 0.16% 129
2018
Q1
$13.9M Sell
125,000
-441,371
-78% -$49.2M 0.14% 159
2017
Q4
$67.7M Buy
566,371
+33,371
+6% +$3.99M 0.7% 27
2017
Q3
$74.8M Buy
533,000
+368,288
+224% +$51.7M 0.84% 27
2017
Q2
$20M Sell
164,712
-273,522
-62% -$33.3M 0.27% 119
2017
Q1
$53.1M Sell
438,234
-22,916
-5% -$2.78M 0.8% 34
2016
Q4
$56.4M Buy
461,150
+439,900
+2,070% +$53.8M 0.9% 25
2016
Q3
$2.6M Buy
21,250
+11,730
+123% +$1.44M 0.05% 202
2016
Q2
$1.11M Sell
9,520
-15,799
-62% -$1.85M 0.02% 238
2016
Q1
$3.53M Sell
25,319
-162,334
-87% -$22.6M 0.07% 192
2015
Q4
$35.8M Buy
187,653
+6,798
+4% +$1.3M 0.65% 49
2015
Q3
$28.3M Sell
180,855
-444
-0.2% -$69.4K 0.57% 50
2015
Q2
$32.8M Buy
181,299
+170,245
+1,540% +$30.8M 0.63% 48
2015
Q1
$1.92M Buy
11,054
+5,664
+105% +$982K 0.04% 223
2014
Q4
$997K Sell
5,390
-88,743
-94% -$16.4M 0.02% 238
2014
Q3
$15.6M Sell
94,133
-13,144
-12% -$2.18M 0.33% 98
2014
Q2
$16.8M Buy
+107,277
New +$16.8M 0.36% 102